European Reimbursement/Germany
Germany · DiGA · Permanent
Oviva Direkt für Adipositas
Oviva AG (Zweigniederlassung Deutschland)
About this entry
Oviva Direkt für Adipositas is a digital health app from Oviva AG (Zweigniederlassung Deutschland) with a permanent DiGA listing in Germany's DiGA directory (BfArM id 00872). It is indicated for type 1 diabetes. First listed on 2021-10-03. It moved to permanent status on 2023-06-30. The public prescription price is EUR 199.25 for a 90-day unit. German statutory health insurers reimburse prescribed use under the Digital Healthcare Act rules. This page is not legal or reimbursement advice; confirm the current entry on the official BfArM listing.
- App
- Oviva Direkt für Adipositas
- Maker
- Oviva AG (Zweigniederlassung Deutschland)
- Country
- Germany
- Program
- DiGA
- Indication
- type 1 diabetes
- Status
- Permanent
- Indication detail
- E66 Adipositas; E10 Diabetes mellitus, Typ 1; E03 Sonstige Hypothyreose; E23 Unterfunktion und andere Störungen der Hypophyse; E24 Cushing-Syndrom; +2 more
- Indication codes
- E66, E10, E03, E23, E24, E66.00, E66.01
- Listing date
- 2021-10-03
- Permanent since
- 2023-06-30
- Public price
- EUR 199.25 per 90-day unit
- BfArM DiGA id
- 00872
Not legal or reimbursement advice. Confirm the current entry with the official source.